title: Blepharitis and trichomegaly induced by cetuximab.
abstract: This report describes the case of a 41-year old woman in treatment for advanced colorectal cancer who developed severe bilateral blepharitis and trichomegaly after the second dose of cetuximab. Cetuximab-related eyelid toxicity has been described previously; however, its pathogenesis has not yet been clearly established.
authors.affiliation: School of Medicine, University of Sao Paulo, Brazil. prcriado@uol.com.br
authors.forename: Paulo Ricardo
authors.initials: PR
authors.lastname: Criado
authors.forename: Aline Angélica Porto Rocha
authors.initials: AA
authors.lastname: Lima
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001762:Blepharitis / Q000139:chemically induced*; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D006983:Hypertrichosis / Q000139:chemically induced*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab